Our New Home in Rösslimatt
A new chapter is beginning for around 850 of our employees: at our new headquarters in Lucerne’s Rösslimatt district, colleagues from three Lucerne offices are coming together under one roof. We are excited to begin this new phase together!
Rösslimatt district near Lucerne railway station
Located close to Lake Lucerne, the city center and key transport hubs, our new site brings together colleagues from our previous offices in Lucerne-Citybay, Kriens and Tribschen in a shared working environment for the first time.
Designed for our employees
At MSD, we believe that teams work best in an environment that encourages collaboration while also providing space for focused work.
Our new headquarters has been designed to support different ways of working throughout the day. In addition to open areas for exchange and collaboration, there are also quiet zones for concentrated work.
There are also thoughtfully designed spaces for breaks, spontaneous conversations with colleagues, or engaging in movement.
Collaboration that enables innovation
The new building will bring our teams closer together. We will work more closely with one another, exchange ideas more frequently in our daily work, and share knowledge faster. This will enable the generation of new ideas and will make cross-functional collaboration easier.
The “One Roof” concept creates a space for creativity, scientific excellence and strong collaboration, while strengthening MSD’s ability to align innovation and research with the greatest possible benefit for patients and to develop solutions for previously unmet medical needs.
Sustainably built and certified
The new headquarters in Rösslimatt supports our goal of reaching net-zero greenhouse gas emissions by 2045. In line with all MSD buildings in Switzerland, the new headquarters in Lucerne is powered by renewable energy.
Our MSD sites in Schachen and Zurich
More than 400 specialist employees from around the world work at the Schachen site on the development and testing of innovative biological medicines. From here, medicines for clinical trials are also exported worldwide, and one of only three global laboratories dedicated to investigating counterfeit medicines is operated.
Since 2021, around 250 employees have been working at The Circle at Zurich Airport to advance research, data generation, and the development of new medicines and vaccines. Teams from Medical Affairs, Clinical Development, Market Access and Marketing Operations drive important projects for MSD in Switzerland and around the world.
CH-NON-03274, 03/2026
